|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 33 of 47 found articles
| Title: |
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial |
| Author: |
Llovet, Josep M Kudo, Masatoshi Merle, Philippe Meyer, Tim Qin, Shukui Ikeda, Masafumi Xu, Ruocai Edeline, Julien Ryoo, Baek-Yeol Ren, Zhenggang Masi, Gianluca Kwiatkowski, Mariusz Lim, Ho Yeong Kim, Jee Hyun Breder, Valeriy Kumada, Hiromitsu Cheng, Ann-Lii Galle, Peter R Kaneko, Shuichi Wang, Anran Mody, Kalgi Dutcus, Corina Dubrovsky, Leonid Siegel, Abby B Finn, Richard S |
| Appeared in: |
Lancet oncology |
| Paging: | Volume 24 () nr. 12 pages 1399-1410 |
| Year: |
2023 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 33 of 47 found articles
| << previous | next >> |